Abiopharma

🔍 Pickering Evan (Executive)

Company: APPFOLIO INC (APPF)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Sold 80 shares of Class A Common Stock at $199.54 per share (Direct)
  Date: 2026-08-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,814.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 54 shares of Class A Common Stock at $199.54 per share (Direct)
  Date: 2026-08-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,760.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 27 shares of Class A Common Stock at $199.54 per share (Direct)
  Date: 2026-08-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,733.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 39 shares of Class A Common Stock at $199.54 per share (Direct)
  Date: 2026-08-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,694.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 64 shares of Class A Common Stock at $199.54 per share (Direct)
  Date: 2026-08-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,630.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 141 shares of Class A Common Stock at $202.01 per share (Direct)
  Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,489.00 | transaction_form_type: 4 | Footnotes: F6
• Sold 161 shares of Class A Common Stock at $199.12 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,328.00 | transaction_form_type: 4 | Footnotes: F6
• Sold 161 shares of Class A Common Stock at $201.01 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,167.00 | transaction_form_type: 4 | Footnotes: F6, F7

Footnotes:

• F1: Consists of Class A Common Stock withheld by the Issuer to satisfy the minimum tax withholding obligations of the Reporting Person arising in connection with the vesting on August 10, 2026 of the performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on January 29, 2025 pursuant to the Issuer's 2025 Omnibus Incentive Plan.
• F2: Consists of Class A Common Stock withheld by the Issuer to satisfy the minimum tax withholding obligations of the Reporting Person arising in connection with the vesting on August 10, 2026 of the time-based restricted stock units ("RSUs") previously granted to the Reporting Person on January 27, 2026 pursuant to the Issuer's 2025 Omnibus Plan.
• F3: Consists of Class A Common Stock withheld by the Issuer to satisfy the minimum tax withholding obligations of the Reporting Person arising in connection with the vesting on August 10, 2026 of the RSUs previously granted to the Reporting Person on January 28, 2025 pursuant to the Issuer's 2025 Omnibus Plan.
• F4: Consists of Class A Common Stock withheld by the Issuer to satisfy the minimum tax withholding obligations of the Reporting Person arising in connection with the vesting on August 10, 2026 of the RSUs previously granted to the Reporting Person on March 5, 2024 pursuant to the Issuer's 2015 Stock Incentive Plan.
• F5: Consists of Class A Common Stock withheld by the Issuer to satisfy the minimum tax withholding obligations of the Reporting Person arising in connection with the vesting on August 10, 2026 of the RSUs previously granted to the Reporting Person on March 6, 2023 pursuant to the Issuer's 2015 Stock Incentive Plan.
• F6: These shares were sold pursuant to a plan adopted by the Reporting Person on or around March 13, 2026.
• F7: This transaction was executed in multiple trades with sales prices ranging from $201.00 to $201.01. The price reported above reflects the weighted average sales price for the cumulative trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer information regarding the individual trades.